MagDI Australia Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 13, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

August 31, 2026

Conditions
ObesityType 2 Diabetes
Interventions
DEVICE

Magnet System, DI Biofragmentable

Anastomoses achieved by magnetic compression.

Trial Locations (4)

2217

Dr. Mark Magdy (affiliated with St. George Private Hospital), Sydney

6150

St. John of God Health Care, Inc., Murdoch

Unknown

Calvary Health Care Adelaide Limited, Adelaide

Upper GI Surgery, Sydney

Sponsors
All Listed Sponsors
lead

GT Metabolic Solutions, Inc.

INDUSTRY

NCT06473831 - MagDI Australia Study | Biotech Hunter | Biotech Hunter